Intravenous administration is expected to become an important trend for delivering OVs, with cell membrane–coated delivery strategies attracting attention due to their inherent immune camouflage and targeting potential.
← all excerpts
Advances in oncolytic virus delivery strategies and challenges in clinical translation.
1
—
—